Cavs’ Thompson Hit With 25-game Drug Suspension | The Sporting Base
[google-translator]

Cavs’ Thompson hit with 25-game drug suspension

January 24, 2024

Cavs’ Thompson hit with 25-game drug suspension

Cleveland Cavaliers big Tristan Thompson has been suspended for 25 games without pay after violating the league’s Anti-Drug Program.

Thompson tested positive for ibutamoren and SARM LGD-4033, the league announced.

The 32-year-old signed a one-year deal with Cleveland this past summer after finishing last season with the Lakers.

In the absence of Evan Mobley, Thompson has proven to be a handy option for head coach J.B. Bickerstaff having averaged 12.4 minutes per game across 36 games.

Thompson was drafted by the Cavs back in 2011 and spent nine seasons with the franchise before parting ways with them at the end of the 2019/20 season.

He started all 21 games of Cleveland’s 2016 title run averaging 10.3 ppg and 10.1 rpg to help drag them back from a 3-1 deficit to overcome the Warriors in the Finals.


Fill In The Form Below To Receive Our NBA News & Tips Via Email!

  • This field is for validation purposes and should be left unchanged.

Tell Us What You Think Below

September 13, 2025

Jack Draper won't compete for rest of 2025 because of an arm injury

There is no doubt that Great Britain's Jack Draper has had an outstanding 2025 season However, it is going to end earlier for the world number seven than he anticipated On Monday of this week, it was Read More

September 13, 2025

Packers off to a great start after win over Commanders

The Green Bay Packers are off to a 2-0 start to the 2025 National Football League regular season So far they have beaten two franchises that had great seasons in 2024 In week one, the Packers beat Read More

September 13, 2025

Opinion: Lleyton Hewitt fortunate to only get two week suspension

One of the biggest stories in tennis over the last week was the fact that Australian tennis legend Lleyton Hewitt of Adelaide was allowed to captain Australia in Davis Cup action in Sydney this Read More